Immuneering Corp (IMRX)
1.47
-0.07
(-4.55%)
USD |
NASDAQ |
May 17, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
Immuneering Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Total Long Term Debt (Quarterly) Benchmarks
Geron Corp | 82.74M |
SELLAS Life Sciences Group Inc | -- |
Elicio Therapeutics Inc | -- |
Vistagen Therapeutics Inc | 0.00 |
ADMA Biologics Inc | 130.85M |